PE20000557A1 - Derivados de 8-fenilxantina - Google Patents
Derivados de 8-fenilxantinaInfo
- Publication number
- PE20000557A1 PE20000557A1 PE1999000459A PE00045999A PE20000557A1 PE 20000557 A1 PE20000557 A1 PE 20000557A1 PE 1999000459 A PE1999000459 A PE 1999000459A PE 00045999 A PE00045999 A PE 00045999A PE 20000557 A1 PE20000557 A1 PE 20000557A1
- Authority
- PE
- Peru
- Prior art keywords
- purin
- dioxo
- tetrahydro
- methyl
- refers
- Prior art date
Links
- ACCCXSZCOGNLFL-UHFFFAOYSA-N 8-phenyl-3,7-dihydropurine-2,6-dione Chemical class N1C=2C(=O)NC(=O)NC=2N=C1C1=CC=CC=C1 ACCCXSZCOGNLFL-UHFFFAOYSA-N 0.000 title abstract 2
- NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 abstract 2
- -1 HYDROXY, CARBAMOYL Chemical class 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 206010002383 Angina Pectoris Diseases 0.000 abstract 1
- MIKUYHXYGGJMLM-GIMIYPNGSA-N Crotonoside Natural products C1=NC2=C(N)NC(=O)N=C2N1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O MIKUYHXYGGJMLM-GIMIYPNGSA-N 0.000 abstract 1
- NYHBQMYGNKIUIF-UHFFFAOYSA-N D-guanosine Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(CO)C(O)C1O NYHBQMYGNKIUIF-UHFFFAOYSA-N 0.000 abstract 1
- 208000010228 Erectile Dysfunction Diseases 0.000 abstract 1
- 206010057671 Female sexual dysfunction Diseases 0.000 abstract 1
- 208000010412 Glaucoma Diseases 0.000 abstract 1
- 206010020772 Hypertension Diseases 0.000 abstract 1
- 102000004861 Phosphoric Diester Hydrolases Human genes 0.000 abstract 1
- 108090001050 Phosphoric Diester Hydrolases Proteins 0.000 abstract 1
- 102000011016 Type 5 Cyclic Nucleotide Phosphodiesterases Human genes 0.000 abstract 1
- 108010037581 Type 5 Cyclic Nucleotide Phosphodiesterases Proteins 0.000 abstract 1
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical class [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 abstract 1
- 206010006451 bronchitis Diseases 0.000 abstract 1
- 229940029575 guanosine Drugs 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 201000001881 impotence Diseases 0.000 abstract 1
- 206010022000 influenza Diseases 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 208000002551 irritable bowel syndrome Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 150000004712 monophosphates Chemical class 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/12—Acyclic radicals, not substituted by cyclic structures attached to a nitrogen atom of the saccharide radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
- C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Surgery (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
SE REFIERE A DERIVADOS DE 8-FENILXANTINA DE FORMULA I, DONDE R1, R2, Y R3 SON H, ALQUENILO, ALQUINILO, CICLOALQUILO, ALQUILCARBAMOILO; R4 O R5 JUNTO CON N FORMAN UN ANILLO DE 3-7 MIEMBROS CON 1-4 HETEROATOMOS, OPCIONALMENTE SUSTITUIDO CON 1-2 HALOGENO, HIDROXI, CARBAMOILO, HIDROXICARBONILO, ALCOXICARBONILO, AMINO, ENTRE OTROS; R6 ES H, ALQUILO; Y EL GRUPO -SO2NR4R5 EN LA POSICION 4 o 5 DEL FENILO. SON COMPUESTOS PREFERIDOS 3-(3-BUTIL-1-METIL-2,6-DIOXO-2,3,6,7-TETRAHIDRO-1H-PURIN-8-IL)-4-PROPOXI-N-PIRIDIN-4-ILBENCENOSULFONAMIDA, 4-ETOXI-3-(1-METIL-2,6-DIOXO-3-PROPIL-2,3,6,7-TETRAHIDRO-1H-PURIN-8-IL)-N-(1H-[1,2,4]TRIAZOL-3-IL)BENCENOSULFONAMIDA, ENTRE OTROS. TAMBIEN SE REFIERE A UN PROCEDIMIENTO PARA LA PREPARACION. EL COMPUESTO I ES UN INHIBIDOR POTENTE DE FOSFODIESTERASA ESPECIFICA DE GUANOSINA 3`,5'-MONOFOSFATO CICLICA Y EN PARTICULAR DE LA FOSFODIESTERASA 5 POR LO QUE PUEDE SER UTIL PARA EL TRATAMIENTO DE ANGINA, HIPERTENSION, FALLAS DE CORAZON CONGESTIVAS, INFARTO, ASMA, BRONQUITIS, DISFUNCION ERECTIL MASCULINA, DISFUNCION SEXUAL FEMENINA, GLAUCOMA, SINDROME DE INTESTINO IRRITABLE
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES9801152 | 1998-06-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20000557A1 true PE20000557A1 (es) | 2000-07-20 |
Family
ID=8304000
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE1999000459A PE20000557A1 (es) | 1998-06-03 | 1999-05-31 | Derivados de 8-fenilxantina |
Country Status (5)
| Country | Link |
|---|---|
| AR (1) | AR018619A1 (es) |
| AU (1) | AU4501199A (es) |
| CO (1) | CO5021199A1 (es) |
| PE (1) | PE20000557A1 (es) |
| WO (1) | WO1999062905A1 (es) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2166270B1 (es) * | 1999-07-27 | 2003-04-01 | Almirall Prodesfarma Sa | Derivados de 8-fenil-6,9-dihidro-(1,2,4,)triazolo(3,4-i)purin-5-ona. |
| GB0007934D0 (en) * | 2000-03-31 | 2000-05-17 | Darwin Discovery Ltd | Chemical compounds |
| GB0008694D0 (en) * | 2000-04-07 | 2000-05-31 | Novartis Ag | Organic compounds |
| US7019136B2 (en) | 2000-04-07 | 2006-03-28 | Novartis, Ag | 8-quinolinxanthine and 8-isoquinolinxanthine derivatives as PDE 5 inhibitors |
| US6919337B2 (en) | 2000-04-07 | 2005-07-19 | Novartis, Ag | 8-Quinolinxanthine and 8-isoquinolinxanthine derivatives as PDE 5 inhibitors |
| DE60105020T2 (de) * | 2000-06-07 | 2005-08-18 | Almirall-Prodesfarma S.A. | 6-phenylpyrrolopyrimidindion derivate |
| WO2002012246A1 (en) * | 2000-08-09 | 2002-02-14 | Almirall Prodesfarma S.A. | Pyrrolotriazolopyrimidinone derivatives |
| US6821978B2 (en) | 2000-09-19 | 2004-11-23 | Schering Corporation | Xanthine phosphodiesterase V inhibitors |
| CN1127506C (zh) | 2001-06-29 | 2003-11-12 | 刘宝顺 | 一种治疗阳痿的新化合物 |
| CN1315835C (zh) | 2001-08-28 | 2007-05-16 | 先灵公司 | 多环鸟嘌呤磷酸二酯酶v抑制剂 |
| US6943171B2 (en) | 2001-11-09 | 2005-09-13 | Schering Corporation | Polycyclic guanine derivative phosphodiesterase V inhibitors |
| US11666888B2 (en) | 2018-02-05 | 2023-06-06 | Bio-Rad Laboratories, Inc. | Chromatography resin having an anionic exchange-hydrophobic mixed mode ligand |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3347290A1 (de) * | 1983-12-28 | 1985-07-11 | Dr. Karl Thomae Gmbh, 7950 Biberach | Neue 2-phenyl-imidazole, ihre herstellung und diese verbindungen enthaltende arzneimittel |
| GB8817651D0 (en) * | 1988-07-25 | 1988-09-01 | Smith Kline French Lab | Chemical compounds |
| GB9213623D0 (en) * | 1992-06-26 | 1992-08-12 | Pfizer Ltd | Therapeutic agents |
-
1999
- 1999-05-26 AU AU45011/99A patent/AU4501199A/en not_active Abandoned
- 1999-05-26 WO PCT/EP1999/003644 patent/WO1999062905A1/en not_active Ceased
- 1999-05-31 PE PE1999000459A patent/PE20000557A1/es not_active Application Discontinuation
- 1999-06-02 AR ARP990102608A patent/AR018619A1/es unknown
- 1999-06-02 CO CO99034567A patent/CO5021199A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU4501199A (en) | 1999-12-20 |
| AR018619A1 (es) | 2001-11-28 |
| WO1999062905A1 (en) | 1999-12-09 |
| CO5021199A1 (es) | 2001-03-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20000557A1 (es) | Derivados de 8-fenilxantina | |
| EA200200337A1 (ru) | ПРОИЗВОДНЫЕ ПИРАЗОЛО[4,3-d]ПИРИМИДИНА | |
| PE20030845A1 (es) | Compuestos de espiro-hidantoina utiles como agentes anti-inflamatorios | |
| PE20010854A1 (es) | USO DE DERIVADOS DE PIRIMIDINA 4 SUSTITUIDOS COMO ANTAGONISTAS DE LOS RECEPTORES DE GLUTAMATO mGluR1 | |
| UY25671A1 (es) | Procedimiento para preparar imidazotrazinonas sustituidas por 2-fenilo | |
| PE20000702A1 (es) | Formulaciones intranasales para tratar trastornos sexuales | |
| PE20020228A1 (es) | Compuestos organicos como inhibidores de 3',5' guanosin monofosfato ciclico fosfodiesterasa | |
| PE20030759A1 (es) | Uso de ureas de benzotiazoles | |
| EA200101203A1 (ru) | Производные пурина | |
| PE20010401A1 (es) | DERIVADOS DE 8-FENIL-6,9-DIHIDRO-[1,2,4] TRIAZOL [3,4-i] PURIN-5-ONA COMO INHIBIDORES DE FOSFODIESTERASA ESPECIFICA DE GMP CICLICO | |
| PE20010736A1 (es) | PIRAZOL-[4,3-d]-PIRIMIDIN-7-ONA COMO INHIBIDORES DE LA 3`,5'-GUANOSINMONOFOSFATO CICLICO FOSFODIESTERASA | |
| PE20020514A1 (es) | Aminas heterociclicas y fenilazacicloalcanos sustituidos para el tratamiento del sindrome de piernas inquietas | |
| EA200000969A1 (ru) | ИНГИБИТОРЫ цГМБ ФДЭ5 НА ОСНОВЕ ПИРАЗОЛПИРИМИДИНОНА ДЛЯ ЛЕЧЕНИЯ ПОЛОВЫХ ДИСФУНКЦИЙ | |
| PE20010629A1 (es) | Derivados de triazolpiridinamina como ligandos de receptores de adenosina | |
| PE20011269A1 (es) | DERIVADOS DE 9-(5-HETEROARILTETRAHIDROFURANIL)-PURINA COMO AGONISTAS SELECTIVOS DEL RECEPTOR A2a DE LA ADENOSINA | |
| PE20030415A1 (es) | Derivados policiclicos de guanina como inhibidores de fosfodiesterasa v | |
| DE3687601D1 (de) | (4-piperidinylmethyl und hetero)purine. | |
| ATE161267T1 (de) | Antivirales 4'-thio-pyrimidin-nukleosid | |
| PE1998A1 (es) | DERIVADOS DE BENZO [g] QUINOLINA | |
| UA27901C2 (uk) | Похідні 7-(2-аміноетил)бензотіазолону, що проявляють агоністичну активність по відношенню до бета2-адренорецепторів, фармацевтична композиція, спосіб їх отримання та проміжні сполуки | |
| PE20030208A1 (es) | Derivados de indirubina que contienen azufre, su preparacion y uso | |
| KR910700253A (ko) | N_6-치환-9-메틸아데닌: 신규한 부류의 아데노신 수용체 길항질 | |
| MY123083A (en) | Acyclic nucleoside derivatives | |
| ES8606304A1 (es) | Un procedimiento para preparar derivados de tiazina | |
| EA200300629A1 (ru) | Конденсированные производные пурина как антагонисты рецепторов аденозина a |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application declared void or lapsed |